Jeff Jorgensen

545 total citations
6 papers, 313 citations indexed

About

Jeff Jorgensen is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Jeff Jorgensen has authored 6 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Hematology, 2 papers in Molecular Biology and 1 paper in Genetics. Recurrent topics in Jeff Jorgensen's work include Acute Myeloid Leukemia Research (2 papers), Hematopoietic Stem Cell Transplantation (1 paper) and Cell Adhesion Molecules Research (1 paper). Jeff Jorgensen is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), Hematopoietic Stem Cell Transplantation (1 paper) and Cell Adhesion Molecules Research (1 paper). Jeff Jorgensen collaborates with scholars based in United States, Netherlands and Poland. Jeff Jorgensen's co-authors include Douglas B. Gould, Marion Jeanne, Valerie Valant, Cassandre Labelle‐Dumais, Steven M. Greenberg, Jonathan Rosand, Grazia M.S. Mancini, Jack Favor, W. Berkeley Kauffman and David Marín and has published in prestigious journals such as Circulation, The American Journal of Human Genetics and Leukemia.

In The Last Decade

Jeff Jorgensen

6 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeff Jorgensen United States	4	111	95	91	68	47	6	313
Dania S. Khalil Saudi Arabia	8	142 1.3×	42 0.4×	36 0.4×	19 0.3×	140 3.0×	11	322
Malcolm Rabie Israel	9	108 1.0×	109 1.1×	16 0.2×	36 0.5×	23 0.5×	17	312
H. Kawano Japan	5	97 0.9×	161 1.7×	78 0.9×	32 0.5×	6 0.1×	5	362
Ying Zhang Chen Japan	7	159 1.4×	83 0.9×	11 0.1×	27 0.4×	49 1.0×	7	313
Jodi L. Klessner United States	6	203 1.8×	42 0.4×	34 0.4×	11 0.2×	19 0.4×	6	390
Shaunta Guha Ireland	10	319 2.9×	55 0.6×	25 0.3×	10 0.1×	45 1.0×	12	479
Koichi Miyagi Japan	11	50 0.5×	68 0.7×	41 0.5×	20 0.3×	8 0.2×	16	347
Gulzhakhan Sadvakassova Canada	9	210 1.9×	89 0.9×	8 0.1×	23 0.3×	20 0.4×	13	341
Andres Kulla Estonia	10	168 1.5×	29 0.3×	24 0.3×	24 0.4×	6 0.1×	15	372
Julie Soblet Belgium	7	101 0.9×	242 2.5×	11 0.1×	23 0.3×	46 1.0×	18	490

Countries citing papers authored by Jeff Jorgensen

Since Specialization

Citations

This map shows the geographic impact of Jeff Jorgensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Jorgensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Jorgensen more than expected).

Fields of papers citing papers by Jeff Jorgensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff Jorgensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Jorgensen. The network helps show where Jeff Jorgensen may publish in the future.

Co-authorship network of co-authors of Jeff Jorgensen

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff Jorgensen. A scholar is included among the top collaborators of Jeff Jorgensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff Jorgensen. Jeff Jorgensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Kadia, Tapan M., Nicholas J. Short, Gautam Borthakur, et al.. (2022). P506: ACHIEVEMENT OF MEASURABLE RESIDUAL DISEASE CLEARANCE IS A STRONGER PREDICTOR OF PATIENT OUTCOME THAN TREATMENT INTENSITY IN NEWLY DIAGNOSED PATIENTS WITH ACUTE MYELOID LEUKEMIA. HemaSphere. 6. 405–406. 1 indexed citations

2.

Thompson, Philip A., Christine B. Peterson, Paolo Strati, et al.. (2018). Serial minimal residual disease (MRD) monitoring during first-line FCR treatment for CLL may direct individualized therapeutic strategies. Leukemia. 32(11). 2388–2398. 24 indexed citations

3.

Oran, Betül, Jeff Jorgensen, David Marín, et al.. (2016). Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia. Haematologica. 102(1). 110–117. 47 indexed citations

4.

Jeanne, Marion, Jeff Jorgensen, & Douglas B. Gould. (2015). Molecular and Genetic Analyses of Collagen Type IV Mutant Mouse Models of Spontaneous Intracerebral Hemorrhage Identify Mechanisms for Stroke Prevention. Circulation. 131(18). 1555–1565. 95 indexed citations

5.

Jeanne, Marion, Cassandre Labelle‐Dumais, Jeff Jorgensen, et al.. (2011). COL4A2 Mutations Impair COL4A1 and COL4A2 Secretion and Cause Hemorrhagic Stroke. The American Journal of Human Genetics. 90(1). 91–101. 145 indexed citations

6.

Stauning, P., H. Lühr, Michael E. Purucker, et al.. (2003). OIST- Proceedings. 4'th Oersted International Science Team Conference. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact